<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://jem.rupress.org">
<title>Latest Articles</title>
<link>http://jem.rupress.org</link>
<description>JEM RSS Feed -- Latest Articles</description>
<prism:eIssn>1540-9538</prism:eIssn>
<prism:publicationName>Journal of Experimental Medicine</prism:publicationName>
<prism:issn>0022-1007</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20091320v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20091280v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20091167102109cv1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20090872v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20090778v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20090389102109cv1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20082745v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20612iti1v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20091579v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20091107v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20082401v1?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/jem.20612iti2v1?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://jem.rupress.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://jem.rupress.org/icons/banner/title.gif">
<title>Journal of Experimental Medicine</title>
<url>http://jem.rupress.org/icons/banner/title.gif</url>
<link>http://jem.rupress.org</link>
</image>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20091320v1?rss=1">
<title><![CDATA[Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20091320v1?rss=1</link>
<description><![CDATA[
<p>The H2AX core histone variant is phosphorylated in chromatin around DNA double strand breaks (DSBs) and functions through unknown mechanisms to suppress antigen receptor locus translocations during V(D)J recombination. Formation of chromosomal coding joins and suppression of translocations involves the ataxia telangiectasia mutated and DNA-dependent protein kinase catalytic subunit serine/threonine kinases, each of which phosphorylates H2AX along cleaved antigen receptor loci. Using Abelson transformed pre&ndash;B cell lines, we find that H2AX is not required for coding join formation within chromosomal V(D)J recombination substrates. Yet we show that H2AX is phosphorylated along cleaved Ig DNA strands and prevents their separation in G1 phase cells and their progression into chromosome breaks and translocations after cellular proliferation. We also show that H2AX prevents chromosome breaks emanating from unrepaired RAG endonuclease-generated TCR-/ locus coding ends in primary thymocytes. Our data indicate that histone H2AX suppresses translocations during V(D)J recombination by creating chromatin modifications that stabilize disrupted antigen receptor locus DNA strands to prevent their irreversible dissociation. We propose that such H2AX-dependent mechanisms could function at additional chromosomal locations to facilitate the joining of DNA ends generated by other types of DSBs.</p>
]]></description>
<dc:creator><![CDATA[Yin, B., Savic, V., Juntilla, M. M., Bredemeyer, A. L., Yang-Iott, K. S., Helmink, B. A., Koretzky, G. A., Sleckman, B. P., Bassing, C. H.]]></dc:creator>
<dc:date>Mon, 02 Nov 2009 08:06:56 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091320</dc:identifier>
<dc:title><![CDATA[Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20091320v1</prism:object>
<prism:publicationDate>2009-11-02</prism:publicationDate>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20091280v1?rss=1">
<title><![CDATA[Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20091280v1?rss=1</link>
<description><![CDATA[
<p>Both class switch recombination (CSR) and somatic hypermutation (SHM) require transcription and the trans-acting factor activation-induced cytidine deaminase (AID), and must be up-regulated during antigen-dependent differentiation of B lymphocytes. To test the role of the heavy chain 3' enhancers in both CSR and SHM, we used a BAC transgene of the entire heavy chain constant region locus. Using Cre-loxP recombination to delete a 28-kb region that contains the four known 3' heavy chain enhancers, we isolated lines of BAC transgenic mice with an intact heavy chain locus and paired lines in the same chromosomal insertion site lacking the 3' enhancers. Intact heavy chain transgenes undergo CSR to all heavy chain genes and mutate their transgenic VDJ exon. In paired transgenes lacking the 3' enhancer region, CSR to most heavy chain genes is reduced to ~1% of the levels for intact heavy chain loci; SHM is also reduced. Finally, we find that in B cells with a transgene lacking the 3' enhancers, interchromosomal recombination between the transgenic VDJ exon and the endogenous heavy chain C genes is more easily detected than CSR within the transgene.</p>
]]></description>
<dc:creator><![CDATA[Dunnick, W. A., Collins, J. T., Shi, J., Westfield, G., Fontaine, C., Hakimpour, P., Papavasiliou, F. N.]]></dc:creator>
<dc:date>Mon, 02 Nov 2009 08:06:58 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091280</dc:identifier>
<dc:title><![CDATA[Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20091280v1</prism:object>
<prism:publicationDate>2009-11-02</prism:publicationDate>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20091167102109cv1?rss=1">
<title><![CDATA[Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20091167102109cv1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ferch, U., Kloo, B., Gewies, A., Pfander, V., Duwel, M., Peschel, C., Krappmann, D., Ruland, J.]]></dc:creator>
<dc:date>Mon, 02 Nov 2009 08:06:58 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091167102109c</dc:identifier>
<dc:title><![CDATA[Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20091167102109cv1</prism:object>
<prism:publicationDate>2009-11-02</prism:publicationDate>
<prism:section>Corrections</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20090872v1?rss=1">
<title><![CDATA[The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20090872v1?rss=1</link>
<description><![CDATA[
<p>Growth-restricted fetuses are at risk for a variety of lifelong medical conditions. Preeclampsia, a life-threatening hypertensive disorder of pregnancy, is associated with fetuses who suffer from intrauterine growth restriction (IUGR). Recently, emerging evidence indicates that preeclamptic women harbor AT<SUB>1</SUB> receptor agonistic autoantibodies (AT<SUB>1</SUB>-AAs) that contribute to the disease features. However, the exact role of AT<SUB>1</SUB>-AAs in IUGR and the underlying mechanisms have not been identified. We report that these autoantibodies are present in the cord blood of women with preeclampsia and retain the ability to activate AT<SUB>1</SUB> receptors. Using an autoantibody-induced animal model of preeclampsia, we show that AT<SUB>1</SUB>-AAs cross the mouse placenta, enter fetal circulation, and lead to small fetuses with organ growth retardation. AT<SUB>1</SUB>-AAs also induce apoptosis in the placentas of pregnant mice, human villous explants, and human trophoblast cells. Finally, autoantibody-induced IUGR and placental apoptosis are diminished by either losartan or an autoantibody-neutralizing peptide. Thus, these studies identify AT<SUB>1</SUB>-AA as a novel causative factor of preeclampsia-associated IUGR and offer two possible underlying mechanisms: a direct detrimental effect on fetal development by crossing the placenta and entering fetal circulation, and indirectly through AT<SUB>1</SUB>-AA&ndash;induced placental damage. Our findings highlight AT<SUB>1</SUB>-AAs as important therapeutic targets.</p>
]]></description>
<dc:creator><![CDATA[Irani, R. A., Zhang, Y., Blackwell, S. C., Zhou, C. C., Ramin, S. M., Kellems, R. E., Xia, Y.]]></dc:creator>
<dc:date>Mon, 02 Nov 2009 08:06:52 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090872</dc:identifier>
<dc:title><![CDATA[The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20090872v1</prism:object>
<prism:publicationDate>2009-11-02</prism:publicationDate>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20090778v1?rss=1">
<title><![CDATA[Niche recycling through division-independent egress of hematopoietic stem cells]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20090778v1?rss=1</link>
<description><![CDATA[
<p>Hematopoietic stem cells (HSCs) are thought to reside in discrete niches through stable adhesion, yet previous studies have suggested that host HSCs can be replaced by transplanted donor HSCs, even in the absence of cytoreductive conditioning. To explain this apparent paradox, we calculated, through cell surface phenotyping and transplantation of unfractionated blood, that ~1&ndash;5% of the total pool of HSCs enters into the circulation each day. Bromodeoxyuridine (BrdU) feeding experiments demonstrated that HSCs in the peripheral blood incorporate BrdU at the same rate as do HSCs in the bone marrow, suggesting that egress from the bone marrow to the blood can occur without cell division and can leave behind vacant HSC niches. Consistent with this, repetitive daily transplantations of small numbers of HSCs administered as new niches became available over the course of 7 d led to significantly higher levels of engraftment than did large, single-bolus transplantations of the same total number of HSCs. These data provide insight as to how HSC replacement can occur despite the residence of endogenous HSCs in niches, and suggest therapeutic interventions that capitalize upon physiological HSC egress.</p>
]]></description>
<dc:creator><![CDATA[Bhattacharya, D., Czechowicz, A., Ooi, A.G. L., Rossi, D. J., Bryder, D., Weissman, I. L.]]></dc:creator>
<dc:date>Mon, 02 Nov 2009 08:06:53 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090778</dc:identifier>
<dc:title><![CDATA[Niche recycling through division-independent egress of hematopoietic stem cells]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20090778v1</prism:object>
<prism:publicationDate>2009-11-02</prism:publicationDate>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20090389102109cv1?rss=1">
<title><![CDATA[The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20090389102109cv1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kugathasan, L., Ray, J. B., Deng, Y., Rezaei, E., Dumont, D. J., Stewart, D. J.]]></dc:creator>
<dc:date>Mon, 02 Nov 2009 08:06:59 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090389102109c</dc:identifier>
<dc:title><![CDATA[The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20090389102109cv1</prism:object>
<prism:publicationDate>2009-11-02</prism:publicationDate>
<prism:section>Corrections</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20082745v1?rss=1">
<title><![CDATA[Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20082745v1?rss=1</link>
<description><![CDATA[
<p>Leukocyte migration across endothelial cell borders (paracellular) and through endothelial cells (transcellular) appear to be distinct processes. During paracellular migration, membrane from a parajunctional reticulum of interconnected vesicles, the endothelial lateral border recycling compartment (LBRC), moves to surround the leukocyte in a kinesin-mediated, microtubule-dependent manner. We show that transcellular migration likewise requires targeted trafficking of LBRC membrane. We show that in addition to platelet/endothelial cell adhesion molecule (PECAM; CD31), CD99 and junctional adhesion molecule A (JAM-A), but apparently not vascular endothelial cell&ndash;specific cadherin (cadherin 5, CD144), are components of the LBRC. During transcellular migration, LBRC membrane invests the transmigrating leukocyte. Intracellular adhesion molecule 1 (ICAM-1) on the apical endothelial surface is enriched around adherent leukocytes. Depolymerization of microtubules has no effect on ICAM-1 enrichment but blocks targeted trafficking of LBRC membrane and transcellular migration by &gt;90%. Similar to their effects on paracellular transmigration, antibodies against PECAM or CD99, but not JAM-A, block transcellular migration. We conclude that similar molecular mechanisms promote both para- and transcellular migration.</p>
]]></description>
<dc:creator><![CDATA[Mamdouh, Z., Mikhailov, A., Muller, W. A.]]></dc:creator>
<dc:date>Mon, 02 Nov 2009 08:06:55 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082745</dc:identifier>
<dc:title><![CDATA[Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20082745v1</prism:object>
<prism:publicationDate>2009-11-02</prism:publicationDate>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20612iti1v1?rss=1">
<title><![CDATA[Vacant spots for stem cells]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20612iti1v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Maxmen, A.]]></dc:creator>
<dc:date>Mon, 02 Nov 2009 08:07:00 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20612iti1</dc:identifier>
<dc:title><![CDATA[Vacant spots for stem cells]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20612iti1v1</prism:object>
<prism:publicationDate>2009-11-02</prism:publicationDate>
<prism:section>In This Issue</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20091579v1?rss=1">
<title><![CDATA[Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20091579v1?rss=1</link>
<description><![CDATA[
<p>Semen is the main vector for HIV-1 dissemination worldwide. It contains three major sources of infectious virus: free virions, infected leukocytes, and spermatozoa-associated virions. We focused on the interaction of HIV-1 with human spermatozoa and dendritic cells (DCs). We report that heparan sulfate is expressed in spermatozoa and plays an important role in the capture of HIV-1. Spermatozoa-attached virus is efficiently transmitted to DCs, macrophages, and T cells. Interaction of spermatozoa with DCs not only leads to the transmission of HIV-1 and the internalization of the spermatozoa but also results in the phenotypic maturation of DCs and the production of IL-10 but not IL-12p70. At low values of extracellular pH (~6.5 pH units), similar to those found in the vaginal mucosa after sexual intercourse, the binding of HIV-1 to the spermatozoa and the consequent transmission of HIV-1 to DCs were strongly enhanced. Our observations support the notion that far from being a passive carrier, spermatozoa acting in concert with DCs might affect the early course of sexual transmission of HIV-1 infection.</p>
]]></description>
<dc:creator><![CDATA[Ceballos, A., Remes Lenicov, F., Sabatte, J., Rodriguez Rodrigues, C., Cabrini, M., Jancic, C., Raiden, S., Donaldson, M., Agustin Pasqualini, R., Marin-Briggiler, C., Vazquez-Levin, M., Capani, F., Amigorena, S., Geffner, J.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 13:53:20 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091579</dc:identifier>
<dc:title><![CDATA[Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20091579v1</prism:object>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20091107v1?rss=1">
<title><![CDATA[Identity of the elusive IgM Fc receptor (Fc{micro}R) in          humans]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20091107v1?rss=1</link>
<description><![CDATA[
<p>Although Fc receptors (FcRs) for switched immunoglobulin (Ig) isotypes have been                    extensively characterized, FcR for IgM (Fc&micro;R) has defied identification.                    By retroviral expression and functional cloning, we have identified a                    complementary DNA (cDNA) encoding a bona fide Fc&micro;R in human B-lineage                    cDNA libraries. Fc&micro;R is defined as a transmembrane sialoglycoprotein of                    ~60 kD, which contains an extracellular Ig-like domain homologous to two                    other IgM-binding receptors (polymeric Ig receptor and Fc/&micro;R)                    but exhibits an exclusive Fc&micro;-binding specificity. The cytoplasmic tail                    of Fc&micro;R contains conserved Ser and Tyr residues, but none of the Tyr                    residues match the immunoreceptor tyrosine-based activation, inhibitory, or                    switch motifs. Unlike other FcRs, the major cell types expressing Fc&micro;R                    are adaptive immune cells, including B and T lymphocytes. After antigen-receptor                    ligation or phorbol myristate acetate stimulation, Fc&micro;R expression was                    up-regulated on B cells but was down-modulated on T cells, suggesting                    differential regulation of Fc&micro;R expression during B and T cell                    activation. Although this receptor was initially designated as Fas apoptotic                    inhibitory molecule 3, or TOSO, our results indicate that Fc&micro;R per se has                    no inhibitory activity in Fas-mediated apoptosis and that such inhibition is                    only achieved when anti-Fas antibody of an IgM but not IgG isotype is used for                    inducing apoptosis.</p>
]]></description>
<dc:creator><![CDATA[Kubagawa, H., Oka, S., Kubagawa, Y., Torii, I., Takayama, E., Kang, D.-W., Gartland, G. L., Bertoli, L. F., Mori, H., Takatsu, H., Kitamura, T., Ohno, H., Wang, J.-Y.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 13:53:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091107</dc:identifier>
<dc:title><![CDATA[Identity of the elusive IgM Fc receptor (Fc{micro}R) in          humans]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20091107v1</prism:object>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20082401v1?rss=1">
<title><![CDATA[The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20082401v1?rss=1</link>
<description><![CDATA[
<p>The bloodstream is an important route of dissemination of invading pathogens. Most of the small bloodborne pathogens, like bacteria or viruses, are filtered by the spleen or liver sinusoids and presented to the immune system by dendritic cells (DCs) that probe these filters for the presence of foreign antigen (Ag). However, larger pathogens, like helminths or infectious emboli, that exceed 20 &micro;m are mostly trapped in the vasculature of the lung. To determine if Ag trapped here can be presented to cells of the immune system, we used a model of venous embolism of large particulate Ag (in the form of ovalbumin [OVA]-coated Sepharose beads) in the lung vascular bed. We found that large Ags were presented and cross-presented to CD4 and CD8 T cells in the mediastinal lymph nodes (LNs) but not in the spleen or liver-draining LNs. Dividing T cells returned to the lungs, and a short-lived infiltrate consisting of T cells and DCs formed around trapped Ag. This infiltrate was increased when the Toll-like receptor 4 was stimulated and full DC maturation was induced by CD40 triggering. Under these conditions, OVA-specific cytotoxic T lymphocyte responses, as well as humoral immunity, were induced. The T cell response to embolic Ag was severely reduced in mice depleted of CD11c<sup>hi</sup> cells or Ly6C/G<sup>+</sup> cells but restored upon adoptive transfer of Ly6C<sup>hi</sup> monocytes. We conclude that the lung vascular filter represents a largely unexplored site of immune induction that traps large bloodborne Ags for presentation by monocyte-derived DCs.</p>
]]></description>
<dc:creator><![CDATA[Willart, M. A.M., Jan de Heer, H., Hammad, H., Soullie, T., Deswarte, K., Clausen, B. E., Boon, L., Hoogsteden, H. C., Lambrecht, B. N.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 13:53:22 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082401</dc:identifier>
<dc:title><![CDATA[The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20082401v1</prism:object>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/jem.20612iti2v1?rss=1">
<title><![CDATA[HIV sticks to sperm]]></title>
<link>http://jem.rupress.org/cgi/content/short/jem.20612iti2v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Maxmen, A.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 13:53:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20612iti2</dc:identifier>
<dc:title><![CDATA[HIV sticks to sperm]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;jem.20612iti2v1</prism:object>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:section>In This Issue</prism:section>
</item>

</rdf:RDF>